Read your latest personalised notifications
Sign in
No account yet? Start here
Don't miss out
Ok, got it
Access the Working Group homepage
Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation. Int J Cardiol. 2018 Nov 15;271:113-114. doi: 10.1016/j.ijcard.2018.06.117.
Myocarditis and cardiomyopathy. Current Opinion in Cardiology. Buggey J, ElAamm CA. 2018 Mar 9. doi: 10.1097/HCO.0000000000000514. [Epub ahead of print]
Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy. Current Opinion in Cardiology. Publish Ahead of Print. Van Linthout S, Tschöpe C. 2018 Mar 9; DOI: 10.1097/HCO.0000000000000515
Novel insights in HFpEF, cardiomyopathies, and myocarditis. Lüscher TF. Eur Heart J. 2018 Mar 7;39(10):819-822. doi: 10.1093/eurheartj/ehy105
Still poor prognosis for patients with giant cell myocarditis in the era of temporary mechanical circulatory supports. Ammirati E, Camici PG. Int J Cardiol. 2018 Feb 15;253:122-123. doi: 10.1016/j.ijcard.2017.10.124
Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort. Montero S, Aissaoui N, Tadié JM, Bizouarn P, Scherrer V, Persichini R, Delmas C, Rolle F, Besnier E, Le Guyader A, Combes A, Schmidt M. Int J Cardiol. 2018 Feb 15;253:105-112. doi: 10.1016/j.ijcard.2017.10.053
The immunoproteasome-specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis. Althof N, Goetzke CC, Kespohl M, Voss K, Heuser A, Pinkert S, Kaya Z, Klingel K, Beling A. EMBO Mol Med. 2018 Jan 2. pii: e8089. doi: 10.15252/emmm.201708089
On the Road from Gene to Therapy in Inherited Cardiomyopathies. Heart Failure Clinics. Limongelli G, Bossone E, Elliott PM, Day SM. 2018 Apr;14(2):xi-xv. doi: 10.1016/j.hfc.2018.01.003
Genetic Infiltrative Cardiomyopathies. Heart Failure Clinics. Sweet ME, Mestroni L, Taylor MRG. 2018 Apr;14(2):215-224. doi: 10.1016/j.hfc.2017.12.003
Diagnostic Criteria, Genetics, and Molecular Basis of Arrhythmogenic Cardiomyopathy. Heart Failure Clinics. Basso C, Pilichou K, Bauce B, Corrado D, Thiene G. 2018 Apr;14(2):201-213. doi: 10.1016/j.hfc.2018.01.002
Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis. Siddiqui WJ, Aggarwal S, Rafique M, Singh S, Kutalek S, Eisen HJ. Heart Fail Rev. 2018 Jan 30. doi: 10.1007/s10741-018-9671-6. [Epub ahead of print] Review
Does Sport Participation Worsen the Clinical Course of Hypertrophic Cardiomyopathy? Clinical Outcome of Hypertrophic Cardiomyopathy in Athletes. Pelliccia A, Lemme E, Maestrini V, Di Paolo FM, Pisicchio C, Di Gioia G, Caselli S. Circulation. 2018 Jan 30;137(5):531-533. doi: 10.1161/CIRCULATIONAHA.117.031725. No abstract available
Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart. Saberi S, Day SM. Circulation. 2018 Jan 30;137(5):419-421. doi: 10.1161/CIRCULATIONAHA.117.029989
Heart. 2018 Oct 1. pii: heartjnl-2018-313532. doi: 10.1136/heartjnl-2018-313532. [Epub ahead of print]
Incidence and Prognosis of Pericarditis After ST-Elevation Myocardial Infarction (from the Acute Coronary Syndrome Israeli Survey 2000 to 2013 Registry Database). Lador A, Hasdai D, Mager A, Porter A, Goldenberg I, Shlomo N, Vorobeichik D, Beigel R, Kornowski R, Iakobishvili Z. Am J Cardiol. 2017 Dec 23. pii: S0002-9149(17)31920-3. doi: 10.1016/j.amjcard.2017.12.006
The role of colchicine in pericardial syndromes. Lazaros G, Imazio M, Brucato A, Vlachopoulos C, Lazarou E, Vassilopoulos D, Tousoulis D. Curr Pharm Des. 2018 Jan 15. doi: 10.2174/1381612824666180116101823. [Epub ahead of print]
Constrictive pericarditis: diagnosis, management and clinical outcomes. Welch TD. Heart. 2017 Nov 25. pii: heartjnl-2017-311683. doi: 10.1136/heartjnl-2017-311683. [Epub ahead of print] Review.
TranslatiOnal Registry for CardiomyopatHies (TORCH) - rationale and first results. Seyler C, Meder B, Weis T, Schwaneberg T, Weitmann K, Hoffmann W, Katus HA, Dösch A. ESC Heart Fail. 2017 Aug;4(3):209-215. doi: 10.1002/ehf2.12145.
Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and A Novel Class of Biomarkers for Heart Failure. Meder B1, Haas J1, Sedaghat-Hamedani F1, Kayvanpour E1, Frese K1, Lai A2, Nietsch R2, Scheiner C2, Mester S2, Martins Bordalo D2, Amr A2, Dietrich C3, Pils D4, Siede D5, Hund H2, Bauer AS6, Holzer DB2, Ruhparwar A7, Mueller-Hennessen M2, Weichenhan D8, Plass C8, Weis TM1, Backs J5, Wuerstle ML3, Keller A9, Katus HA10, Posch AE3. Circulation. 2017 Aug 24. pii: CIRCULATIONAHA.117.027355. doi: 10.1161/CIRCULATIONAHA.117.027355. [Epub ahead of print]
Role of Genetic Testing in Inherited Cardiovascular Disease: A Review. Cirino AL, Harris S, Lakdawala NK, Michels M, Olivotto I, Day SM, Abrams DJ, Charron P, Caleshu C, Semsarian C, Ingles J, Rakowski H, Judge DP, Ho CY. JAMA Cardiol. 2017 Aug 9. doi: 10.1001/jamacardio.2017.2352. [Epub ahead of print]
Outcome predictors in dilated cardiomyopathy or myocarditis. Kuethe F, Franz M, Jung C, Porrmann C, Reinbothe F, Schlattmann P, Egerer R, Mall G. Eur J Clin Invest. 2017 Jul;47(7):513-523. doi: 10.1111/eci.12772. Epub 2017 Jun 26.
Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy. Yogasundaram H, Kim D, Oudit O, Thompson RB, Weidemann F, Oudit GY. Can J Cardiol. 2017 Jul;33(7):883-897. doi: 10.1016/j.cjca.2017.04.015. Epub 2017 May 4. Review.
Therapeutic Strategies Targeting Inherited Cardiomyopathies. Varian K, Tang WHW. Curr Heart Fail Rep. 2017 Jun 28. doi: 10.1007/s11897-017-0346-8. [Epub ahead of print] Review
The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. Ho CY, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, Canter CE, Jefferies JL, Murphy AM, Cirino AL, Abraham TP, Taylor M, Mestroni L, Bluemke DA, Jarolim P, Shi L, Sleeper LA, Seidman CE, Orav EJ; HCMNet Investigators. JAMA Cardiol. 2017 Feb 22. doi: 10.1001/jamacardio.2016.5670.
Assessing the Phenotypic Burden of Preclinical Sarcomeric Hypertrophic Cardiomyopathy-New Assessments to Guide Diagnosis and Management. Tardiff JC. JAMA Cardiol. 2017 Feb 22. doi: 10.1001/jamacardio.2016.5677
Beating, Fast and Slow. Jani SM, Nallamothu BK, Cooper LT, Smith A, Fazel R. N Engl J Med. 2017 Jul 6;377(1):72-78. doi: 10.1056/NEJMcps1608688.
Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis. Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, Petrella D, Garascia A, Pedrotti P, Roghi A, Bonacina E, Moreo A, Bottiroli M, Gagliardone MP, Mondino M, Ghio S, Totaro R, Turazza FM, Russo CF, Oliva F, Camici PG, Frigerio M. Circulation. 2017 Aug 8;136(6):529-545. doi: 10.1161/CIRCULATIONAHA.117.026386. Epub 2017 Jun 2.
Myocarditis: A Clinical Overview. Caforio ALP, Malipiero G, Marcolongo R, Iliceto S. Curr Cardiol Rep. 2017 Jul;19(7):63. doi: 10.1007/s11886-017-0870-x. Review
Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis. Kaese S, Larbig R, Rohrbeck M, Frommeyer G, Dechering D, Olligs J, Schönhofer-Merl S, Wessely R, Klingel K, Seebohm G, Eckardt L. PLoS One. 2017 Jun 23;12(6):e0180029. doi: 10.1371/journal.pone.0180029. eCollection 2017
Differentiation of Takotsubo syndrome from infarct-like myocarditis. Stiermaier T, Lurz P. Int J Cardiol. 2017 Sep 1;242:44. doi: 10.1016/j.ijcard.2017.05.020
Survival and Left Ventricular Function Changes in Fulminant Versus Non-Fulminant Acute Myocarditis. Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, Petrella D, Garascia A, Pedrotti P, Roghi A, Bonacina E, Moreo A, Bottiroli M, Gagliardone MP, Mondino MG, Ghio S, Totaro R, Turazza FM, Russo CF, Oliva F, Camici PG, Frigerio M. Circulation. 2017 Jun 2. pii: CIRCULATIONAHA.117.026386. doi: 10.1161/CIRCULATIONAHA.117.026386. [Epub ahead of print]
Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance.von Knobelsdorff-Brenkenhoff F, Schüler J, Dogangüzel S, Dieringer MA, Rudolph A, Greiser A, Kellman P, Schulz-Menger J. Circ Cardiovasc Imaging. 2017 Feb;10(2). pii: e005242. doi: 10.1161/CIRCIMAGING.116.005242
Why Edema Is a Matter of the Heart. Friedrich MG. Circ Cardiovasc Imaging. 2017 Feb;10(2). pii: e006062. doi: 10.1161/CIRCIMAGING.117.006062.
Biventricular endomyocardial biopsy in patients with suspected myocarditis: Feasibility, complication rate and additional diagnostic value. Stiermaier T, Föhrenbach F, Klingel K, Kandolf R, Boudriot E, Sandri M, Linke A, Rommel KP, Desch S, Schuler G, Thiele H, Lurz P. Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34594-6. doi: 10.1016/j.ijcard.2016.12.103
Is colchicine really harmful in viral myocarditis? Maestroni S, Imazio M, Valenti A, Assolari A, Brucato A. Int J Cardiol. 2017 Feb 15;229:42. doi:10.1016/j.ijcard.2016.10.031.
Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality. Søgaard KK, Farkas DK, Ehrenstein V, Bhaskaran K, Bøtker HE, Sørensen HT. Circulation. 2017 Jun 29. pii: CIRCULATIONAHA.116.024041. doi: 10.1161/CIRCULATIONAHA.116.024041. [Epub ahead of print]
Acute and Recurrent Pericarditis: Still Idiopathic? Brucato A, Valenti A, Maisch B. J Am Coll Cardiol. 2017 Jun 6;69(22):2775. doi: 10.1016/j.jacc.2017.02.072. No abstract available.
Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology. Rehman KA, Betancor J, Xu B, Kumar A, Rivas CG, Sato K, Wong LP, Asher CR, Klein AL. Clin Cardiol. 2017 Sep 5. doi: 10.1002/clc.22770. [Epub ahead of print] Review.
Interleukin-1 Blockade for the Treatment of Pericarditis. Buckley L, Viscusi MM, Van Tassell B, Abbate A. Eur Heart J Cardiovasc Pharmacother. 2017 Jun 19. doi: 10.1093/ehjcvp/pvx018. [Epub ahead of print]
Surgical Treatment of Constrictive Pericarditis. Depboylu BC, Mootoosamy P, Vistarini N, Testuz A, El-Hamamsy I, Cikirikcioglu M. Tex Heart Inst J. 2017 Apr 1;44(2):101-106. doi: 10.14503/THIJ-16-5772. eCollection 2017 Apr. Review.
Fluorodeoxyglucose PET/CT Predicts Response to Steroid Therapy in Constrictive Pericarditis. Chang SA, Choi JY, Kim EK, Hyun SH, Jang SY, Choi JO, Park SJ, Lee SC, Park SW, Oh JK. J Am Coll Cardiol. 2017 Feb 14;69(6):750-752. doi: 10.1016/j.jacc.2016.11.059.
Recurrent pericarditis. Imazio M, Battaglia A, Gaido L, Gaita F. Rev Med Interne. 2017 Feb 6. pii: S0248-8663(16)31045-1. doi: 10.1016/j.revmed.2016.12.006
Recent advances in the management of pericardial diseases. Celentani D, Di Cuia M, Imazio M, Gaita F. Hosp Pract (1995). 2016 Dec;44(5):266-273.
Our mission: To reduce the burden of cardiovascular disease.